معرفی
Kevin Tyler is an Associate Professor at the Norwich Medical School, University of East Anglia. His research focuses on parasite virulence mechanisms in tropical diseases such as Chagas disease, leishmaniasis, and cryptosporidiosis. He holds adjunct positions at King Abdulaziz University and serves as Editor-in-Chief of Virulence. Tyler’s work bridges basic science with clinical training, including directing the MRes Clinical Science program. He leads projects funded by Wellcome Trust, European Commission, and industry partners, investigating vaccine development, microbial genomics, and host-parasite interactions. Recent studies include microbiome influences on cryptosporidiosis and drug mechanisms against trypanosomes.
Educational Background
- BSc Immunology & Molecular Biology, King's College London (1990)
- MSc Applied Molecular Biology of Infectious Disease, London School of Hygiene & Tropical Medicine (1993)
- PhD Biochemistry, University of Manchester (1998)
Research Interests
Tyler’s lab explores parasite surface molecules involved in host specificity and virulence. Current projects include a Merck-funded Cryptosporidium vaccine study and bioinformatics analysis of drug action. Collaborations span global institutions, focusing on neglected tropical diseases and avian trichomonosis.
Grants & Recognition
His work is supported by grants from Wellcome Trust, European Commission, and RCUK. He is a Distinguished Adjunct Professor at King Abdulaziz University and chairs the British Society for Parasitology. Recent grants include an £8M NIHR Health Protection Unit in Gastrointestinal Infections and a Royal Embassy of Saudi Arabia-funded bioinformatics studentship.
Labs & Teams
Current lab members include Georgina Hurle (technician), Dalal Ardan (PhD Trichomonas gallinae), and Meshaal Sabir (PhD Leishmania). Alumni include Claire Butler (postdoc on Trypanosoma cruzi host response) and Johanna Nader (PhD Cryptosporidium virulence).
